Macrophage engulfment of a cell or nanoparticle is regulated by unavoidable opsonization, a species-specific 'Marker of Self' CD47, and target physical properties.

Professional phagocytes of the mononuclear phagocyte system (MPS), especially ubiquitous macrophages, are commonly thought to engulf or not a target based strictly on 'eat me' molecules such as Antibodies. The target might be a viable 'self' cell or a drug-delivering nanoparticle, or it might be a cancer cell or a microbe. 'Marker of Self' CD47 signals into a macrophage to inhibit the acto-myosin cytoskeleton that makes engulfment efficient. In adhesion of any cell, the same machinery is generally activated by rigidity of target surfaces, and recent results confirm phagocytosis is likewise driven by the rigidity typical of microbes and many synthetics. Basic insights are already being applied in order to make macrophages eat cancer or to delay nanoparticle clearance for better drug delivery and imaging.

[1]  J. Vacher,et al.  Macrophage Fusion Is Controlled by the Cytoplasmic Protein Tyrosine Phosphatase PTP-PEST/PTPN12 , 2013, Molecular and Cellular Biology.

[2]  Arno Kwade,et al.  Atomic force microscopy studies on the nanomechanical properties of Saccharomyces cerevisiae. , 2010, Colloids and surfaces. B, Biointerfaces.

[3]  I. Weissman,et al.  CD47 Is Upregulated on Circulating Hematopoietic Stem Cells and Leukemia Cells to Avoid Phagocytosis , 2009, Cell.

[4]  J. Stender,et al.  Environment Drives Selection and Function of Enhancers Controlling Tissue-Specific Macrophage Identities , 2015, Cell.

[5]  P. Low,et al.  Clustering of integral membrane proteins of the human erythrocyte membrane stimulates autologous IgG binding, complement deposition, and phagocytosis. , 1991, The Journal of biological chemistry.

[6]  K. Beningo,et al.  Fc-receptor-mediated phagocytosis is regulated by mechanical properties of the target. , 2002, Journal of cell science.

[7]  S. Sánchez-Ramón,et al.  The chemokine CXCL12 regulates monocyte-macrophage differentiation and RUNX3 expression. , 2011, Blood.

[8]  R. Mebius,et al.  Structure and function of the spleen , 2005, Nature Reviews Immunology.

[9]  J. Rao,et al.  Nanomechanical analysis of cells from cancer patients. , 2007, Nature nanotechnology.

[10]  Samir Mitragotri,et al.  Role of target geometry in phagocytosis. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[11]  Josephine C. Adams,et al.  The evolution of thrombospondins and their ligand-binding activities. , 2010, Molecular biology and evolution.

[12]  C. Lagenaur,et al.  Role of CD47 as a marker of self on red blood cells. , 2000, Science.

[13]  Jens-Peter Volkmer,et al.  The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors , 2012, Proceedings of the National Academy of Sciences.

[14]  A. Aderem,et al.  Mechanisms of phagocytosis in macrophages. , 1999, Annual review of immunology.

[15]  T. K. van den Berg,et al.  On the mechanism of CD47 targeting in cancer , 2012, Proceedings of the National Academy of Sciences.

[16]  Herbert J Meiselman,et al.  Antibody against poly(ethylene glycol) adversely affects PEG‐asparaginase therapy in acute lymphoblastic leukemia patients , 2007, Cancer.

[17]  B. Geiger,et al.  Actomyosin-generated tension controls the molecular kinetics of focal adhesions , 2011, Journal of Cell Science.

[18]  S. Greenberg,et al.  Phagocytic signaling strategies: Fc(gamma)receptor-mediated phagocytosis as a model system. , 2001, Seminars in immunology.

[19]  D. Soto-Pantoja,et al.  Inhibitory signaling through signal regulatory protein-α is not sufficient to explain the antitumor activities of CD47 antibodies , 2012, Proceedings of the National Academy of Sciences.

[20]  P. Low,et al.  Folate-conjugated liposomes preferentially target macrophages associated with ovarian carcinoma. , 2004, Cancer letters.

[21]  S. Greenberg,et al.  Phagocytic signaling strategies: Fcγreceptor-mediated phagocytosis as a model system , 2001 .

[22]  Joseph M. DeSimone,et al.  Using mechanobiological mimicry of red blood cells to extend circulation times of hydrogel microparticles , 2011, Proceedings of the National Academy of Sciences.

[23]  Dennis E Discher,et al.  Self inhibition of phagocytosis: the affinity of 'marker of self' CD47 for SIRPalpha dictates potency of inhibition but only at low expression levels. , 2010, Blood cells, molecules & diseases.

[24]  Inhibition of “self” engulfment through deactivation of myosin-II at the phagocytic synapse between human cells , 2008 .

[25]  E. Korn,et al.  Blebbistatin and blebbistatin-inactivated myosin II inhibit myosin II-independent processes in Dictyostelium. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[26]  H. Gresham,et al.  CD 47-Signal Regulatory Protein a ( SIRP a ) Regulates Fc g and Complement Receptor – mediated Phagocytosis , 2001 .

[27]  Philip S Low,et al.  Changes in the properties of normal human red blood cells during in vivo aging , 2013, American journal of hematology.

[28]  J. Dick,et al.  Polymorphism in Sirpa modulates engraftment of human hematopoietic stem cells , 2007, Nature Immunology.

[29]  Dennis E. Discher,et al.  Nuclear Lamin-A Scales with Tissue Stiffness and Enhances Matrix-Directed Differentiation , 2013, Science.

[30]  R. Lipowsky,et al.  Cell rigidity and shape override CD47's "self"-signaling in phagocytosis by hyperactivating myosin-II. , 2015, Blood.

[31]  W. Janssen,et al.  Cell-Surface Calreticulin Initiates Clearance of Viable or Apoptotic Cells through trans-Activation of LRP on the Phagocyte , 2005, Cell.

[32]  Dennis E Discher,et al.  Minimal " Self " Peptides That Inhibit Phagocytic Clearance and Enhance Delivery of Nanoparticles References and Notes , 2022 .

[33]  Dai Fukumura,et al.  Multistage nanoparticle delivery system for deep penetration into tumor tissue , 2011, Proceedings of the National Academy of Sciences.

[34]  H. Gresham,et al.  Cd47-Signal Regulatory Protein α (Sirpα) Regulates Fcγ and Complement Receptor–Mediated Phagocytosis , 2001, The Journal of experimental medicine.

[35]  J. Swanson,et al.  The coordination of signaling during Fc receptor‐mediated phagocytosis , 2004, Journal of leukocyte biology.

[36]  Samir Mitragotri,et al.  Long Circulating Nanoparticles via Adhesion on Red Blood Cells: Mechanism and Extended Circulation , 2007, Experimental biology and medicine.

[37]  Michael L Klein,et al.  Emerging Applications of Polymersomes in Delivery: from Molecular Dynamics to Shrinkage of Tumors. , 2007, Progress in polymer science.

[38]  D. Discher,et al.  Crawling from soft to stiff matrix polarizes the cytoskeleton and phosphoregulates myosin-II heavy chain , 2012, The Journal of cell biology.

[39]  Daniel A Fletcher,et al.  Chemotherapy exposure increases leukemia cell stiffness. , 2007, Blood.

[40]  Ronnie H. Fang,et al.  Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.

[41]  S. Greenberg,et al.  Tyrosine phosphorylation of the gamma subunit of Fc gamma receptors, p72syk, and paxillin during Fc receptor-mediated phagocytosis in macrophages. , 1994, The Journal of biological chemistry.

[42]  Kenneth A. Dawson,et al.  Nanoparticle size and surface properties determine the protein corona with possible implications for biological impacts , 2008, Proceedings of the National Academy of Sciences.

[43]  Jens-Peter Volkmer,et al.  Engineered SIRPα Variants as Immunotherapeutic Adjuvants to Anticancer Antibodies , 2013, Science.

[44]  M. Dierich,et al.  IgG Opsonization of HIV Impedes Provirus Formation in and Infection of Dendritic Cells and Subsequent Long-Term Transfer to T Cells1 , 2007, The Journal of Immunology.

[45]  D. Discher,et al.  Shape effects of filaments versus spherical particles in flow and drug delivery. , 2007, Nature nanotechnology.

[46]  Marc Thellier,et al.  The sensing of poorly deformable red blood cells by the human spleen can be mimicked in vitro. , 2011, Blood.

[47]  T. Matozaki,et al.  Autoimmune animal models in the analysis of the CD47-SIRPα signaling pathway. , 2014, Methods.

[48]  Shamik Sen,et al.  Species- and cell type-specific interactions between CD47 and human SIRPalpha. , 2006, Blood.

[49]  J. A. Gimm,et al.  Evaluation of biochemical changes during in vivo erythrocyte senescence in the dog. , 1999, Blood.

[50]  M. Telen,et al.  Rh-related antigen CD47 is the signal-transducer integrin-associated protein. , 1994, The Journal of biological chemistry.

[51]  S. Clare,et al.  Luminal Microbes Promote Monocyte–Stem Cell Interactions Across a Healthy Colonic Epithelium , 2014, The Journal of Immunology.

[52]  I. Weissman,et al.  Reply to Soto-Pantoja et al. and Zhao et al.: Targeting CD47 on human solid tumors , 2012, Proceedings of the National Academy of Sciences.

[53]  I. Amit,et al.  Tissue-Resident Macrophage Enhancer Landscapes Are Shaped by the Local Microenvironment , 2014, Cell.

[54]  T. Matozaki,et al.  Negative Regulation of Phagocytosis in Macrophages by the CD47-SHPS-1 System1 , 2005, The Journal of Immunology.

[55]  Wolfgang A. Weber,et al.  Impact of tumor-specific targeting on the biodistribution and efficacy of siRNA nanoparticles measured by multimodality in vivo imaging , 2007, Proceedings of the National Academy of Sciences.

[56]  A. Barclay,et al.  Signal-regulatory protein α from the NOD mouse binds human CD47 with an exceptionally high affinity – implications for engraftment of human cells , 2014, Immunology.